Using mHealth to Help Black Adults in the Midwest With Opioid/Stimulant Use and Mood Symptoms
Official title: Leveraging mHealth to Promote Recovery From Opioid Use Disorder and Commonly Occurring Mental Health Disorders Among Residents of a Medium-Sized Midwestern City
Run by Washington University School of Medicine · NCT07673380 · Data updated 2026-11-12
This study tests a mobile health program to support recovery and mood in Black adults who use opioids or stimulants and are seeking treatment.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Washington University School of Medicine Academic / other |
| Locations | 1 site (St Louis, Missouri) |
| Status | Recruiting |
| Started | August 31, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | February 28, 2027 |
| Registry record updated | June 29, 2026 |
| Trial ID | NCT07673380 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Black adults (18+) in the U.S. with a history of opioid and/or stimulant use who are seeking treatment and can use English.
✕Probably not a fit
Participants not experiencing benefit may include those who do not engage with the mHealth tools or who have mood symptoms unlikely to respond to the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 2 interventional trial compares recovery and engagement outcomes among Black adults who have used opioids or stimulants and are receiving treatment. Participants are randomized to either the original mHealth recovery program (uMAT-R) or the same program with enhanced community engagement. Recruitment occurs through local substance use treatment facilities and recovery services in a Midwestern city. The study aims to see if adding community engagement improves engagement with the mHealth tools and recovery outcomes. English-speaking adults who are U.S. residents are eligible, while those with cognitive impairment are excluded.
Why it matters
Potential benefit: If successful, the intervention could improve engagement with recovery tools and support mood symptoms for Black adults in substance use treatment.
How similar studies have gone: Previous work has shown mHealth tools can support recovery in diverse populations, with added community engagement potentially enhancing impact.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have a history of opioid and/or stimulant use * Identify as Black and/or African American * Seek treatment at local substance use treatment centers * Fluent in English * U.S. resident * 18 years of age or older at the time of data collection. Exclusion Criteria: * Self-reported cognitive impairment that would limit ability to participate in research.
Where it's running
-
Washington University School of Medicine
St Louis, Missouri, United States Recruiting
Study contacts
- Study coordinator: Hannah Szlyk
- Email: szlyk@wustl.edu
- Phone: 917-836-4225
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Healing Hearts: A Mindfulness App for Parents Navigating Divorce or Separation
A online program tests a self-guided mindfulness app for distressed parents going through divorce or separation, to see if it helps parent and child wellbeing.
-
Serratus vs Erector Spinae Block for Pain After Unilateral Breast Surgery
This trial tests whether serratus posterior superior intercostal plane block or erector spinae plane block reduces chronic pain 3 months after unilateral breast surgery in adult women.
-
Targeting alcohol-opioid co-use among young adults with a new mobile health tool
A mobile health app is being tested to help young adults reduce drinking and opioid use when they occur together.
-
Dexa vs Dexmedetomidine with Bupivacaine in TAP Block for Laparotomy Analgesia
This study tests whether adding dexamethasone or dexmedetomidine to bupivacaine in a TAP block improves postoperative pain control after laparotomy.
-
Stress response with desflurane versus opioid-free TIVA during weight-loss surgery
This study will test whether adding the inhaled anesthetic desflurane to opioid-free anesthesia changes the body's perioperative stress response in people having bariatric (weight-loss) surgery.
-
Erector Spinae Block vs Paravertebral Block for Chronic Pain After Mastectomy
This trial tests whether an erector spinae block can better prevent chronic pain after mastectomy than a paravertebral block in adults 18–80.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.